Purpose Coffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study. Methods The study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires. Results During a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HR calibrated 1.00, 95% CI 0.97-1.04) or with the risk of TC subtypes. Tea consumption (per 100 mL/day) was not associated with the risk of total differentiated TC (HR calibrated 0.98, 95% CI 0.95-1.02) and papillary tumor (HR calibrated 0.99, 95% CI 0.95-1.03), whereas an inverse association was found with follicular tumor risk (HR calibrated 0.90, 95% CI 0.81-0.99), but this association was based on a sub-analysis with a small number of cancer cases. Conclusions In this large prospective study, coffee and tea consumptions were not associated with TC risk.
Introduction
Thyroid cancer (TC) is considered the most common endocrine cancer, and its incidence has been continuously increasing in the last decades [1] , especially due to overdiagnosis [2] . In Europe, the number of new TC cases in 2012 was 53,000 and it is usually threefold more common in women than in men [3] . Differentiated TC, including papillary and follicular carcinoma, represents 90% of TC [4] . Only a few risk factors have been well established for TC, such as history of having a benign thyroid tumor, exposure to ionizing radiation in childhood, and body fatness [4, 5] . Dietary factors, such as nutrients and components (e.g., energy, polyunsaturated fatty acids, alcohol, and flavonoids) [6] [7] [8] and foods (e.g., fish, fruits and vegetables, coffee, and tea) [9] [10] [11] [12] , have been suggested to play a role in TC etiology, although, until now, epidemiological evidence is still very limited and inconclusive [4] .
After water, coffee and tea are the most consumed beverages worldwide in adults [13] . Tea and coffee are rich sources of flavonoids and phenolic acids, respectively [14] . Basic research has shown that these polyphenol classes may play a role in cancer prevention, including TC [15] , through the modulation of enzyme activities and signal transduction pathways related to cellular proliferation, differentiation, apoptosis, inflammation, angiogenesis, and metastasis [16, 17] . However, other coffee and tea constituents, such as caffeine and theophylline, have shown both negative and positive effects in carcinogenesis [18] . Epidemiological evidence on the association between coffee and tea intake and TC risk is limited; a protective association on tea consumption and TC risk was observed in a recent meta-analysis [11] , while no association was found with coffee intake in another meta-analysis [12] . Those results need to be interpreted with caution because of potential biases, since most of the studies published so far were case-control studies and included a small number of TC cases. Therefore, further large cohort studies are warranted.
In the current study, we aimed to investigate the relationships between coffee and tea consumption, and the risk of differentiated TC within the European Prospective Investigation into Cancer and Nutrition (EPIC), a large cohort with a relatively high number of TC cases, and a wide variability in the intake of these beverages.
Materials and methods

Study population
EPIC is an ongoing multi-center cohort study aimed to evaluate the associations between dietary, lifestyle and genetic factors, and cancer risk. The study enrolled 521,324 subjects (70.1% women) between 1992 and 2000, mostly aged between 35 and 70 years, from 23 centers in ten European countries (Denmark, France, Germany, Greece, Italy, The Netherlands, Norway, Spain, Sweden, and United Kingdom). The participants were mostly chosen from the general population with some exceptions. Further details of the study have been previously described [19] . The study was performed in accordance with the Declaration of Helsinki. Moreover, the ethical approval was provided from the review boards of the International Agency for Research on Cancer and local participating centers. Written informed consent was also provided by all study participants. Exclusions before the beginning of the analyses included: participants with missing or null follow-up time or having a prevalent cancer other than non-melanoma skin cancer at baseline (n = 29,332); participants with incomplete information on lifestyle (n = 1277); and participants with dietary data unavailable or considered to be implausible (i.e., participants in the highest and lowest 1% of the distribution for the ratio between energy intake to estimated energy requirement, n = 14,555). Therefore, our analysis included 476,108 participants (333,876 women and 142,232 men).
Dietary and lifestyle assessment
At enrollment, dietary information over the previous 12 months was collected using country/center specific dietary questionnaires [19] . The relative validity and reproducibility of these questionnaires has been previously published [20] . In all countries, dietary questionnaires were self-reported, except in Ragusa and Naples (Italy), Greece, and Spain, where they were administered by trained interviewers. In Norway, data on tea consumption were not collected. Data on consumption of coffee type, i.e., caffeinated and decaffeinated, were only specified in some centers [France, Germany, Greece, Italy (Florence, Varese, and Turin only), The Netherlands, and the United Kingdom]. A standardized computerized 24-h dietary recall was used to obtain a second dietary measurement (between 1995 and 1999) from a random sample of the cohort (n = 36,994) to calibrate dietary measurements across countries and to correct for systematic over-or under-estimation of dietary intakes [21] . The quantity of coffee and tea intake was converted from cups per month, week, or day in the dietary questionnaires into mL/day using the typical sizes of tea/ coffee cups for each center.
Lifestyle questionnaires were used to obtain information on education (used as a proxy for socioeconomic status), smoking status and intensity, alcohol consumption, physical activity levels [22] , oral contraceptive use, menopausal status, and menopausal hormone use. Anthropometry (weight and height) was measured at recruitment by trained personnel, with the exception of Oxford (United Kingdom), Norway, and France, where measurements were self-reported [19] .
Follow-up and case ascertainment
Incident cancer cases were identified through population cancer registries in all countries except France, Germany, and Greece where cases were identified through active follow-up, directly from the participants or next of kin, and confirmed by a combination of methods, such as health insurance records, and cancer and pathology registries. Mortality data were obtained from mortality registries at the regional level or national level. Complete follow-up censoring dates ranged from December 2010 to December 2014, depending on the study center.
The 10th Revision of the International Statistical Classification of Diseases, Injuries, and Causes of Death (ICD-10) was used to code TC (code C73). In this analysis, only differentiated TC cases were included, and therefore, of the 800 TC cases ascertained, anaplastic (n = 9), medullary (n = 37), lymphoma (n = 1) forms, and "other morphologies" (n = 5) of TC cases were excluded. Finally, 748 first primary incident differentiated TC cases were considered: 601 papillary TCs, 109 follicular TCs, and 38 not otherwise specified (NOS) TCs, most likely to be papillary TCs.
Statistical analysis
Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) between coffee and tea consumption and differentiated TC risk. Intakes of coffee and tea were analyzed as continuous variables (increments of 100 mL/day). Coffee consumers were also analyzed using cohort-wide quartiles. Due to the high percentage of tea non-consumers (33.9%), individual tea consumption was classified as non-consumers, and cohortwide tertiles established among consumers. Tests for linear trend were performed by attributing the median of each category as score. Age was the primary time variable in all models. Entry time was age at recruitment and exit time was age at the first diagnosis of any type of cancer, death, or censoring date (loss or end of follow-up), whichever occurred first. Tests and graphs based on Schoenfeld residuals were used to assess proportional hazard assumptions, which were satisfied. The basic model (model 1) was stratified by sex, age at recruitment (1-year interval), and center. The multivariable model (model 2) was additionally adjusted for body mass index (BMI, continuous variable in kg/m 2 ), smoking status (never, former, current smoker, and unknown), alcohol consumption (g/day), education level (primary, secondary, and unknown), physical activity (inactive, active, and unknown according to the Cambridge Physical Activity Index) [22] , and total energy intake (kcal/ day). In women, model 2 was also adjusted for menopausal status and type (pre-, peri-, post-, and surgical menopause), ever use of oral contraceptives (yes, no, and unknown), and history of infertility problems (yes, no, and unknown).
Separate analyses were performed for differentiated TC subtypes: follicular and papillary tumors. Heterogeneity of risk between TC subtypes was assessed with the Wald test [23] . Possible interactions of coffee/tea consumption with sex, body mass index (categorical variable: BMI < 25 and BMI ≥ 25), tobacco smoking status (never, former, and current smokers), and physical activity (inactive and active) were tested by including an interaction term in the multiadjusted models. Separate BMI-specific models were fitted, because a significant interaction between BMI categories (BMI < 25 and BMI ≥ 25) and coffee intake was detected. Sensitivity analyses were performed by repeating the models after the exclusion of differentiated TC cases diagnosed during the first 2 years of follow-up, since participants may have changed their diets in the pre-diagnostic period. Finally, we also conducted analyses using country-specific levels of coffee consumption instead of overall cohort-wide levels of consumption, because coffee volumes and compositions notably differed among EPIC countries. For all analyses, P values < 0.05 were considered as statistically significant. Statistical analyses were conducted using SAS, version 9.3, software (SAS Institute).
Calibration of dietary data
A calibration method was used to correct for between-center errors and to correct for random and systematic within-person errors. In this method, the 24-HDR values of 36,994 participants were regressed on the main dietary questionnaire values for coffee and tea with adjustment for age at recruitment, center, and total energy intake, and weighting by day of the week and season of the year during which the 24-HDR was collected [24] . Zero consumption values in the main dietary questionnaires were excluded in the regression calibration models, and a zero was directly imputed as a corrected value. Country-and sex-specific calibration models were used to obtain the individual predicted values of dietary exposure for all participants. Cox regression models were then run using the predicted (calibrated) values for each individual on a continuous scale and those results are considered as the main exposure in this study. The standard error of the calibrated coefficient was estimated with bootstrap sampling in the calibration and disease models and repeated 300 times [24] .
Results
Overall, 748 subjects (666 women and 82 men) out of 467,108 participants (333,876 women and 142,232 men) were diagnosed with a first primary incident differentiated TC during the follow-up. The median (percentile 10 and 90%) of coffee consumption was 357 (16-1000) mL/day and 289 (4-857) mL/day in men and women, respectively; the highest intake was in Denmark and the lowest ones in Italy and Spain. The median (percentile 10 and 90%) of tea consumption was 12 (0-625) mL/day and 14 (0-645) mL/day in men and in women, respectively. The highest consumption of tea in both men and women was in the UK, whereas the lowest consumption of tea in men and women was in Spain, Greece, and Sweden (median ≤ 1 mL/day) ( Table 1) .
Participants in the highest quartile of coffee consumption were more likely to be men, current smokers, physically active, highly educated, and to have higher intakes of alcohol and total energy than those in the lowest quartile. Tea consumers in the highest consumption group were more likely to be women, more physically active, highly educated; had lower BMI and waist circumference; consumed less alcohol, tobacco and total energy than non-tea consumers (Supplementary Table 1) .
No association was observed between calibrated coffee consumption per 100 mL/day and the risk of total differentiated TC (HR calibrated 1.00, 95% CI 0.97-1.04), papillary tumor (HR calibrated 1.00, 95% CI 0.96-1.04), and follicular tumor (HR calibrated 1.05, 95% CI 0.96-1.14), (P for heterogeneity = 0.29) (Table 2) . Similarly, null results were found between coffee intake, using both cohort-wide (Table 2) and country-specific quartiles (data not shown), and differentiated TC risk. Similar null results were observed after excluding 77 cases who were diagnosed with differentiated TC within the first 2 years of follow-up.
No significant association was found between calibrated tea intake per 100 mL/day and the risk of total differentiated TC (HR calibrated 0.98, 95% CI 0.95-1.02). A borderline statistically significant heterogeneity was observed between TC site risks for tea intake (P for heterogeneity = 0.055). No statistically association with papillary tumor (HR calibrated 0.99, 95% CI 0.95-1.03) was found, whereas an inverse association was observed with follicular tumor risk (HR calibrated 0.90, 95% CI 0.81-0.99). In the sensitivity analysis after excluding 77 cases who were diagnosed with differentiated TC within the first 2 years of follow-up, the results were almost identical, including the association between calibrated tea intake (per 100 mL/day) and follicular tumor risk (HR calibrated 0.89, 95% CI 0.79-1.00) (data not tabulated).
The risk estimates for coffee consumption and differentiated TC were modified by BMI categories (BMI < 25 and BMI ≥ 25), with a positive association in subjects below BMI 25 , and inverse associations in subjects with BMI 25 and above (P for interaction = 0.009). However, no individual association was statistically significant in either stratum ( Supplementary Table 2 ). No interactions were detected by sex (P = 0.72 and 0.76, respectively), tobacco (P = 0.87 and 0.48, respectively), and physical activity (P = 0.34 and 0.43, respectively).
Discussion
In this large prospective study, we observed no association between both coffee or tea consumption and overall differentiated TC risk in either men or women, or for either papillary or follicular tumors. Similarly to our findings, in a recent meta-analysis of 7 epidemiological studies, including only 2 prospective cohorts (including 109 and 159 TC cases), no association between coffee intake and TC risk was found [12] . Authors of the meta-analysis recommended further prospective studies on this topic evaluating potential differences between sexes, histological subtypes, and coffee types, and estimating dose-response relationships. We were able to investigate most of these issues, since the number of TC cases in our cohort was more than fourfold larger than the previous prospective studies [25, 26] . Our study shows null results in both men and women, as well as in either papillary or follicular tumors. Indeed, the results were not statistically significant using either quartiles or the continuous variable. The collection of data on caffeinated and decaffeinated coffee was limited to a few EPIC centers, which hampers statistical power for these analyses and, therefore, our ability to draw any conclusions on possible associations. To our knowledge, only one population-based case-control study reported separate association estimates for caffeinated and decaffeinated coffee with TC, showing null results for both associations [27] . Moreover, in Europe, coffee brewing methods vary greatly among countries, with Northern populations drinking large quantities of diluted coffee, and Southern populations principally consuming concentrated coffee, such as espressos. Despite the fact that we did not collect data on brewing method, which could have varied by country, no association between coffee and TC risk was observed using country-specific quartiles.
In the present study, no association was found between tea consumption, which, in Europe, is mostly black tea, and overall differentiated TC risk. In 2015, a meta-analysis of 11 studies, including only one cohort study (including 159 TC cases), showed an inverse association between tea intake and overall TC risk for the highest versus the lowest category of tea consumption (risk estimate = 0.77, 95% CI 0.62-0.97) [11] . This association was, however, only detected in the case-control studies, which are more prone to recall bias. In the subgroup analysis by geographic locations, the association was statistically significant only in the US-based studies; however, it was not confirmed in a recent US cohort: the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) prospective study [25] . Regarding histological subtypes, no association was observed with papillary TC risk in our study; whereas an inverse association was detected with follicular TC risk (using the continuous variable but not the categorical one). Cellular and animal experiments have shown protective effects of tea constituents, particularly flavonoids, against TC [15] . Despite the biological plausibility of an inverse association between tea consumption and TC risk and the potential etiological differences between papillary and follicular TC, it is important to bear in mind that, in our study, the number of follicular cancer cases is rather low (n = 109) and this may be the result of multiple comparisons and sub-set analyses. Therefore, the results were probably due to chance. Unfortunately, there were no data on the relationship by histological subtypes in the meta-analysis [11] . Hence, further prospective studies are warranted to evaluate this relationship between tea consumption and follicular TC risk.
Major strengths of our study were its prospective design, the long follow-up, and its large sample size with a relatively high number of TC cases. However, our study had some limitations. First, our results may be influenced by measurement errors in the dietary assessment that may have attenuated our findings, although we partially controlled them using the validated country-specific dietary questionnaire [20] and calibrating the associations using the 24-HDR [24] . Second, diet was only assessed at baseline, and that any potential dietary changes during follow-up are unaccounted for. In addition, coffee data on brewing method were not collected, although differences in brewing methods are larger in participants from different countries than in participants in the same country. Results were almost identical using either cohort-wide or country-specific quartiles of coffee consumption. Moreover, limited data on coffee type (caffeinated or decaffeinated coffee) and no data on tea type (green, black, white, or oolong tea) were available in this study. In addition, some individuals may have modified their diet during the early pre-diagnostic period of the disease, but sensitivity analyses excluding incident cases diagnosed in the first 2 years of follow-up did not alter the risk estimates. Finally, we have adjusted our models for several potential confounders, although the presence of possible residual confounding cannot be excluded.
In conclusion, no association between coffee and tea consumption and the risk of overall differentiated TC were found in this large multi-center European cohort. Null results were also observed between coffee intake and both papillary and follicular TC risk. For tea consumption, our study shows no association and an inverse association with papillary and follicular TC risk, respectively, but these sub-analyses' findings should be interpreted with caution. Future studies capturing coffee brewing methods, using nutritional biomarkers [28] and repeated measurements of coffee and tea intake, during the follow-up might further develop our understanding of the association between tea and coffee consumption and TC risk.
